昭衍新药再涨超4% 本月股价累涨超三成 公司有望受益猴价公允价值收益

Group 1 - The core viewpoint of the article highlights that Zhaoyan New Drug (603127) has seen its stock price increase by over 30% this month, with a current price of 22.14 HKD, reflecting a 4.04% rise at the time of reporting [1] - The price of experimental monkeys has been rising rapidly, currently around 140,000 RMB each, driven by increased demand from preclinical CRO orders and limited supply capacity [1] - According to estimates from Founder Securities, the fair value of experimental monkeys for Zhaoyan New Drug is projected to be 84,900 RMB each in 2024, increasing to 140,000 RMB by Q4 2025, with an estimated additional fair value of approximately 220 million RMB in 2025 based on current monkey inventory [1]